Kidney Cancer Diagnostics And Therapeutics Market By Type (Transitional Cell Cancer, Renal Cell Carcinoma, Renal Sarcoma, Others), By Tests (Biopsy, CT Scan, Cystoscopy, Intravenous Pyelogram, Kidney Ultrasound) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Kidney Cancer Diagnostics And Therapeutics Market By Type (Transitional Cell Cancer, Renal Cell Carcinoma, Renal Sarcoma, Others), By Tests (Biopsy, CT Scan, Cystoscopy, Intravenous Pyelogram, Kidney Ultrasound) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 843 | Pages: 178 | October 2018 | Region: Global


The Global Kidney Cancer Diagnostics and Therapeutics Market was worth $3.47 billion in 2018 and estimated to be growing at a CAGR of 5.64%, to reach $4.57 billion by 2023. Though there has been considerable development in science and technology to tackle cancer, it continues to threaten lives across the world.

Kidney cancer is one of the frequent urologic tumours accounting for around 3% of all human cancers. The frequency rate of renal cell carcinoma has increased gradually in the recent decades.

The growth of the Global Kidney Cancer Diagnostics and Therapeutics Market is mainly driven by factors such as rising aging population, Changes in lifestyle such as increased intake of alcohol and disproportionate smoking, and government policies to provide better care for kidney Cancer. However, high costs of screening tests, minimal success rate in clinical trials, and poor availability of proper cancer care in the emerging regions are restraining the growth of the market.

The Global Kidney Cancer Diagnostics and Therapeutics market is segmented based on Type and Tests. The market for Kidney Cancer Diagnostics and Therapeutics, on the basis of Type it is segmented into Transitional Cell Cancer, Renal cell carcinoma, Renal sarcoma, and Others. On the basis of Tests, the global Kidney Cancer Diagnostics and Therapeutics market is segmented into Biopsy, CT Scan, Cystoscopy, Intravenous pyelogram, Kidney Ultrasound. Biopsy and CT Scan lead the tests segment in the Global Kidney Cancer Diagnostics and Therapeutics market accounting for more than 50% of the market.

The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Rest of the World. North America accounted for the largest share in the global Kidney Cancer Diagnostics and Therapeutics market followed by Asia-Pacific and Europe.  The frequency of this disease was higher in developed countries than in developing nations due to lifestyle factors. However, The Asia-Pacific region is anticipated to increase at the highest CAGR during the forecast period due to factors such as low expense of drug production and the mounting patient base suffering from these diseases.

The major companies dominating the Kidney Cancer Diagnostics and Therapeutics market are GlaxoSmithKline, Bayer, Pfizer, Sanofi S.A, Hoffmann La Roche, Novartis, Abbott Laboratories.

1. Introduction                             

              1.1 Market Definition                  

              1.2 Study Deliverables                

              1.3 Base Currency, Base Year and Forecast Periods                       

              1.4 General Study Assumptions              

2. Research Methodology                                       

              2.1 Introduction                           

              2.2 Research Phases                    

                             2.2.1 Secondary Research          

                             2.2.2 Primary Research

                             2.2.3 Econometric Modelling     

                             2.2.4 Expert Validation 

              2.3 Analysis Design                      

              2.4 Study Timeline                       

3. Overview                                   

              3.1 Executive Summary              

              3.2 Key Inferences                       

              3.3 New Developments              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                

              4.1 Market Drivers                       

              4.2 Market Restraints                  

              4.3 Key Challenges                       

              4.4 Current Opportunities in the Market                           

5. Market Segmentation                                          

              5.1 By Type                     

                             5.1.1 Transitional Cell Cancer    

                             5.1.2 Renal cell carcinoma         

                             5.1.3 Renal sarcoma     

                             5.1.4 Other Cancers      

              5.2 By Tests                     

                             5.2.1 Biopsy      

                             5.2.2 CT Scan    

                             5.2.3 Cystoscopy            

                             5.2.4 Intravenous pyelogram    

                             5.2.5 Kidney Ultrasound             

6. Geographical Analysis                                         

              6.1 North America                       

                             6.1.1 Introduction         

                             6.1.2 United States        

                             6.1.3 Canada    

              6.2 Europe                      

                             6.2.1 Introduction         

                             6.2.2 U.K            

                             6.2.3 Spain        

                             6.2.4 Germany 

                             6.2.5 Italy          

                             6.2.6 France      

              6.3 Asia-Pacific               

                             6.3.1 Introduction         

                             6.3.2 China       

                             6.3.3 India         

                             6.3.4 Japan       

                             6.3.5 South Korea          

                             6.3.6 Australia  

              6.4 Latin America                         

                             6.4.1 Introduction         

                             6.4.2 Brazil        

                             6.4.3 Argentina

                             6.4.4 Mexico     

                             6.4.5 Rest of Latin America        

              6.5 Middle East & Africa                           

                             6.5.1 Introduction         

                             6.5.2 Middle-East          

                             6.5.3 Africa       

7. Pipeline Product Analysis                                    

              7.1 Overview                                 

              7.2 Pipeline Development Landscape                                 

              7.3 Molecular Targets in the Pipeline                                  

              7.4 Clinical Trials                          

                             7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target    

                             7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target             

                             7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.   

8.Strategic Analysis                                    

              8.1 PESTLE analysis                      

                             8.1.1 Political    

                             8.1.2 Economic

                             8.1.3 Social       

                             8.1.4 Technological       

                             8.1.5 Legal         

                             8.1.6 Environmental     

              8.2 Porter’s Five analysis                          

                             8.2.1 Bargaining Power of Suppliers       

                             8.2.2 Bargaining Power of Consumers   

                             8.2.3 Threat of New Entrants    

                             8.2.4 Threat of Substitute Products and Services             

                             8.2.5 Competitive Rivalry within the Industry     

9.Market Leaders' Analysis                                     

              9.1 GlaxoSmithKline                    

                             9.1.1 Overview 

                             9.1.2 Product Analysis  

                             9.1.3 Strategic Evaluation and Operations          

                             9.1.4 Financial analysis 

                             9.1.5 Legal issues           

                             9.1.6 Recent Developments       

                             9.1.7 SWOT analysis      

                             9.1.8 Analyst View         

              9.2 Bayer                         

              9.3 Pfizer                         

              9.4 Sanofi S.A                 

              9.5 Hoffmann La Roche              

              9.6 Novartis                    

              9.7 Abbott Laboratories                            

10.Competitive Landscape                                      

              10.1 Market share analysis                      

              10.2 Merger and Acquisition Analysis                  

              10.3 Agreements, collaborations and Joint Ventures                    

              10.4 New Product Launches                     

11.Expert Opinions                                    

              11.1 Market Outlook                   

              11.2 Investment Opportunities               

Appendix                                       

              a) List of Tables              

              b) List of Figures                           

  • Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Kidney Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Billion)
  2. Global Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  3. Global Transitional Cell Cancer Market By Region, From 2018-2023 (USD Billion)
  4. Global Renal cell carcinoma Market By Region, From 2018-2023 (USD Billion)
  5. Global Renal sarcoma Market By Region, From 2018-2023 (USD Billion)
  6. Global Other Kidney Cancers Market By Region, From 2018-2023 (USD Billion)
  7. Global Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  8. Global Biopsy Market By Region, From 2018-2023 (USD Billion)
  9. Global CT Scan Market By Region, From 2018-2023 (USD Billion)
  10. Global Cystoscopy Market By Region, From 2018-2023 (USD Billion)
  11. Global Intravenous pyelogram Market By Region, From 2018-2023 (USD Billion)
  12. Global Kidney Ultrasound Market By Region, From 2018-2023 (USD Billion)
  13. North America Kidney Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Billion)
  14. North America Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  15. North America Transitional Cell Cancer Market By Region, From 2018-2023 (USD Billion)
  16. North America Renal cell carcinoma Market By Region, From 2018-2023 (USD Billion)
  17. North America Renal sarcoma Market By Region, From 2018-2023 (USD Billion)
  18. North America Other Kidney Cancers Market By Region, From 2018-2023 (USD Billion)
  19. North America Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  20. North America Biopsy Market By Region, From 2018-2023 (USD Billion)
  21. North America CT Scan Market By Region, From 2018-2023 (USD Billion)
  22. North America Cystoscopy Market By Region, From 2018-2023 (USD Billion)
  23. North America Intravenous pyelogram Market By Region, From 2018-2023 (USD Billion)
  24. North America Kidney Ultrasound Market By Region, From 2018-2023 (USD Billion)
  25. United States Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  26. United States Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  27. Canada Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  28. Canada Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  29. Europe Kidney Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Billion)
  30. Europe Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  31. Europe Transitional Cell Cancer Market By Region, From 2018-2023 (USD Billion)
  32. Europe Renal cell carcinoma Market By Region, From 2018-2023 (USD Billion)
  33. Europe Renal sarcoma Market By Region, From 2018-2023 (USD Billion)
  34. Europe Other Kidney Cancers Market By Region, From 2018-2023 (USD Billion)
  35. Europe Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  36. Europe Biopsy Market By Region, From 2018-2023 (USD Billion)
  37. Europe CT Scan Market By Region, From 2018-2023 (USD Billion)
  38. Europe Cystoscopy Market By Region, From 2018-2023 (USD Billion)
  39. Europe Intravenous pyelogram Market By Region, From 2018-2023 (USD Billion)
  40. Europe Kidney Ultrasound Market By Region, From 2018-2023 (USD Billion)
  41. U.K Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  42. U.K Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  43. Spain Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  44. Spain Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  45. Germany Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  46. Germany Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  47. Italy Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  48. Italy Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  49. France Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  50. France Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  51. Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Billion)
  52. Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  53. Asia-Pacific Transitional Cell Cancer Market By Region, From 2018-2023 (USD Billion)
  54. Asia-Pacific Renal cell carcinoma Market By Region, From 2018-2023 (USD Billion)
  55. Asia-Pacific Renal sarcoma Market By Region, From 2018-2023 (USD Billion)
  56. Asia-Pacific Other Kidney Cancers Market By Region, From 2018-2023 (USD Billion)
  57. Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  58. Asia-Pacific Biopsy Market By Region, From 2018-2023 (USD Billion)
  59. Asia-Pacific CT Scan Market By Region, From 2018-2023 (USD Billion)
  60. Asia-Pacific Cystoscopy Market By Region, From 2018-2023 (USD Billion)
  61. Asia-Pacific Intravenous pyelogram Market By Region, From 2018-2023 (USD Billion)
  62. Asia-Pacific Kidney Ultrasound Market By Region, From 2018-2023 (USD Billion)
  63. China Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  64. China Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  65. India Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  66. India Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  67. Japan Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  68. Japan Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  69. South Korea Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  70. South Korea Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  71. Australia Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  72. Australia Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  73. Latin America Kidney Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Billion)
  74. Latin America Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  75. Latin America Transitional Cell Cancer Market By Region, From 2018-2023 (USD Billion)
  76. Latin America Renal cell carcinoma Market By Region, From 2018-2023 (USD Billion)
  77. Latin America Renal sarcoma Market By Region, From 2018-2023 (USD Billion)
  78. Latin America Other Kidney Cancers Market By Region, From 2018-2023 (USD Billion)
  79. Latin America Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  80. Latin America Biopsy Market By Region, From 2018-2023 (USD Billion)
  81. Latin America CT Scan Market By Region, From 2018-2023 (USD Billion)
  82. Latin America Cystoscopy Market By Region, From 2018-2023 (USD Billion)
  83. Latin America Intravenous pyelogram Market By Region, From 2018-2023 (USD Billion)
  84. Latin America Kidney Ultrasound Market By Region, From 2018-2023 (USD Billion)
  85. Brazil Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  86. Brazil Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  87. Argentina Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  88. Argentina Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  89. Mexico Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  90. Mexico Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  91. Middle East & Africa Kidney Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Billion)
  92. Middle East & Africa Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  93. Middle East & Africa Transitional Cell Cancer Market By Region, From 2018-2023 (USD Billion)
  94. Middle East & Africa Renal cell carcinoma Market By Region, From 2018-2023 (USD Billion)
  95. Middle East & Africa Renal sarcoma Market By Region, From 2018-2023 (USD Billion)
  96. Middle East & Africa Other Kidney Cancers Market By Region, From 2018-2023 (USD Billion)
  97. Middle East & Africa Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  98. Middle East & Africa Biopsy Market By Region, From 2018-2023 (USD Billion)
  99. Middle East & Africa CT Scan Market By Region, From 2018-2023 (USD Billion)
  100. Middle East & Africa Cystoscopy Market By Region, From 2018-2023 (USD Billion)
  101. Middle East & Africa Intravenous pyelogram Market By Region, From 2018-2023 (USD Billion)
  102. Middle East & Africa Kidney Ultrasound Market By Region, From 2018-2023 (USD Billion)
  103. Middle East Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  104. Middle East Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
  105. Africa Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2018-2023 (USD Billion)
  106. Africa Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2018-2023 (USD Billion)
Middle-East & Africa Cardiovascular Therapeutic Drugs By Disease (Arteriosclerosis, Cardiac Arrhythmias, Myocardial Infarction, Acute Coronary Syndrome, Peripheral Artery Disease, Coronary Artery Disease, Hypertensi...
Middle East And Africa Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail...
Latin America Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmaci...
Asia Pacific Clostridium Botulinum Market By Product (botulinum Toxin Type A And Botulinum Toxin Type B), By End User (aesthetic And Therapeutics), By Distribution Channel (hospitals, Clinics And Retail Pharmacies) ...
Europe Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmacies) And...
North America Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmaci...
Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmacies) And By Reg...
The Dental Bone Graft Substitutes Market Is Predicted To Reach USD 664.3 Million With A CAGR Of 9.8% According To Market Data Forecast Report....
Middle East And Africa Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal D...
Latin America Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal Defect Reg...
Asia-Pacific Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal Defect Rege...
Europe Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal Defect Regenerati...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2019 Market Data Forecast
All Rights Reserved.